In vivo albumin labeling and lymphatic imaging

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 1, 2015, Pages 208-213

  Wang, Yu ^a,b   Lang, Lixin ^b   Huang, Peng ^b   Wang, Zhe ^b   Jacobson, Orit ^b   Kiesewetter, Dale O ^b   Ali, Iqbal U ^b   Teng, Gaojun ^a   Niu, Gang ^b   Chen, Xiaoyuan ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Albumin; Evans blue; Lymph node; Optical imaging; PET

Indexed keywords

1,4,7 TRIAZACYCLONONANE N,N',N'' TRIACETIC ACID; ALBUMIN; EVANS BLUE; FLUORINE 18; ISOTOPE; UNCLASSIFIED DRUG; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; ALBUMINOID; ALUMINUM DERIVATIVE; ALUMINUM FLUORIDE; FLUORIDE; FLUORINE; HETEROCYCLIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST METASTASIS; FLUORESCENCE IMAGING; IMAGE ANALYSIS; IMAGING; IN VIVO STUDY; INFLAMMATION; INTERSTITIAL FLUID; ISOTOPE LABELING; LABELING INDEX; LYMPH VESSEL; MULTIMODAL IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; DIAGNOSTIC IMAGING; FLUORESCENCE; HINDLIMB; IMAGE PROCESSING; LUMINESCENCE; LYMPH NODE; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY; STAINING;

ANIMALIA;

ALBUMINS; ALUMINUM COMPOUNDS; ANIMALS; DIAGNOSTIC IMAGING; EVANS BLUE; FLUORESCENCE; FLUORIDES; FLUORINE RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HINDLIMB; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LUMINESCENT MEASUREMENTS; LYMPH NODES; LYMPHATIC VESSELS; MICE, INBRED BALB C; MULTIMODAL IMAGING; NEOPLASM METASTASIS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; STAINING AND LABELING;

EID: 84920500544     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1414821112     Document Type: Article

References (36)

1. Swartz MA (2001) The physiology of the lymphatic system. Adv Drug Deliv Rev 50(1-2):3-20.
2. Picker LJ, Butcher EC (1992) Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 10:561-591.
3. Karaman S, Detmar M (2014) Mechanisms of lymphatic metastasis. J Clin Invest 124(3):922-928.
4. Tammela T, Alitalo K (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140(4):460-476.
5. Veronesi U, et al. (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349(9069):1864-1867.
6. Wilhelm AJ, Mijnhout GS, Franssen EJ (1999) Radiopharmaceuticals in sentinel lymphnode detection - An overview. Eur J Nucl Med 26(4, Suppl):S36-S42.
7. Mariani G, et al. (2001) Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 42(8):1198-1215.
8. Mariani G, et al. (2002) Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med 43(6):811-827.
9. Tsopelas C, Sutton R (2002) Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 43(10):1377-1382.
10. Huang X, et al. (2012) Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials 33(17):4370-4378.
11. Kim S, et al. (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22(1):93-97.
12. Verbeek FP, et al. (2014) Near-infrared fluorescence sentinel lymph node mapping in breast cancer: A multicenter experience. Breast Cancer Res Treat 143(2):333-342.
13. Hirano A, et al. (2012) A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients. Ann Surg Oncol 19(13):4112-4116.
14. Koo J, et al. (2012) In vivo non-ionizing photoacoustic mapping of sentinel lymph nodes and bladders with ICG-enhanced carbon nanotubes. Phys Med Biol 57(23):7853-7862.
15. Chi C, et al. (2014) Intraoperative imaging-guided cancer surgery: From current fluorescence molecular imaging methods to future multi-modality imaging technology. Theranostics 4(11):1072-1084.
16. Nguyen QT, Tsien RY (2013) Fluorescence-guided surgery with live molecular navigation - A new cutting edge. Nat Rev Cancer 13(9):653-662.
17. Sengupta J, Ghosh S, Datta P, Gomes A, Gomes A (2014) Physiologically important metal nanoparticles and their toxicity. J Nanosci Nanotechnol 14(1):990-1006.
18. Cody HS, 3rd (1999) Sentinel lymph node mapping in breast cancer. Breast Cancer 6(1):13-22.
19. Kern KA (1999) Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189(6):539-545.
20. Harrell MI, Iritani BM, Ruddell A (2008) Lymph node mapping in the mouse. J Immunol Methods 332(1-2):170-174.
21. Sutton R, Tsopelas C, Kollias J, Chatterton BE, Coventry BJ (2002) Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labeled blue dye in a rabbit model. Surgery 131(1):44-49.
22. 99mTc-Evans blue dye for mapping contiguous lymph node sequences and discriminating the sentinel lymph node in an ovine model. Ann Surg Oncol 13(5):692-700.
23. Niu G, et al. (2014) In vivo labeling of serum albumin for PET. J Nucl Med 55(7):1150-1156.
24. Ellmerer M, et al. (2000) Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion. Am J Physiol Endocrinol Metab 278(2):E352-E356.
25. Van den Broeck W, Derore A, Simoens P (2006) Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 312(1-2):12-19.
26. Niu G, Li Z, Xie J, Le QT, Chen X (2009) PET of EGFR antibody distribution in head and neck squamous cell carcinoma models. J Nucl Med 50(7):1116-1123.
27. Wolfe LS, et al. (2010) Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc Natl Acad Sci USA 107(39):16863-16868.
28. Swartz MA, Hubbell JA, Reddy ST (2008) Lymphatic drainage function and its immunological implications: From dendritic cell homing to vaccine design. Semin Immunol 20(2):147-156.
29. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N (1995) High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36(7):1301-1306.
30. Tokin CA, et al. (2012) The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: A comparative review and meta-analysis of the mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis 29(7):681-686.
31. Tiguert R, et al. (1999) Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 53(2):367-371.
32. Zhang F, Zhu L, Huang X, Niu G, Chen X (2013) Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI. Mol Imaging Biol 15(1):40-47.
33. Pieterman RM, et al. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343(4):254-261.
34. Anonymous (2010) Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, DC).
35. Wu C, et al. (2014) Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors. Theranostics 4(5):546-555.
36. Ruscher K, et al. (2013) Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab 33(8):1225-1234.